undamentalytics Newsletter
Sign in

Illumina, Inc. cash flow statement

In fiscal 2025, Illumina, Inc.'s operations generated $1.08bn of cash; it spent $148m on capital projects, leaving free cash flow of $931m. It returned $742m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Jan 20122012Dec 20122013Dec 20132014Dec 20142015Jan 20162016Jan 20172017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Jan 20232023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations1722733582923865017867798751,1421,0511,0805453924788371,0791,230
Depreciation and amortisation2534564851113127141156179188187251394432354270220
Stock-based pay61729294106153133129164193194194754366380370275270
Capital spending5350786979106143260310296209189208286195128148173
Free cash flow1202232802233073956435195658468428913371062837099311,057
Free cash flow after stock pay59151188129201243510390401653648697−417−260−97339656787
Share buybacks175445708350237274249251201324736000116742421
Shares issued3910262549496724771465961606367564446

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ILMN vs WATILMN vs MTDCRL vs ILMN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Illumina, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Illumina, Inc.